An international team of researchers, including scientists of the University of Groningen, has now demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides, another ...

An international team of researchers, including scientists of the University of Groningen, have now demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides ...

In a surprising turn of events, an international team of scientists has found that lead-208 (208 Pb), the heaviest known "doubly magic" nucleus, exhibits unexpected shape characteristics that ...

Crompton introduces two new product platforms, NUCLEUS and XTECH, focusing on high performance and energy efficiency. Crompton aims to secure a 10% share of the domestic appliances market When ...

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase ...

YARDLEY, Pa.--(BUSINESS WIRE)--Red Nucleus, a leading provider of strategic services across research and development, medical affairs, market access, commercial solutions, and learning and ...

He clicked open a dashboard created by Nucleus Genomics, a Founders Fund-backed startup that gets saliva samples sequenced and then compares the DNA results to extensive data linking health issues ...

Nucleus is revolutionizing this landscape by offering the first genetic test built exclusively for preventative health, analyzing nearly 100% of a person’s genetic sequence – 1,000 times deeper than ...

Two years after emerging with its initial funding round, CDMO Nucleus RadioPharma is going bicoastal, revealing expansions at two sites that the company believes will "significantly improve ...

The Aminoglycosides Market is poised for significant expansion, with projections indicating that the market will grow from USD 1.8 billion in 2023 to approximately USD 2.9 billion by 2033, reflecting ...

Following Nucleus RadioPharma’s 2022 debut, the GE HealthCare- and Mayo Clinic-backed radiopharmaceuticals CDMO is ready to put its production thesis to the test. Nucleus on Tuesday revealed ...